Biotech Values

[DewDiligence]

RPRX – Thanks for weighing in, zipjet. In your opinion, what reason other than the intention to mislead can there be for RPRX to have reported the dropout results the way they did? Before you answer, I’d like to reiterate what I said in #msg-35017508:

Any reasonable person would expect the dropout rate on placebo to be sky-high in a trial whose objective was mitigation of pain, as was the case for the trial in question. Hence the ratio of the placebo dropout rate to the Proellex dropout rate is an inherently bogus metric. What’s much more relevant, IMO, is how many of the patients on Proellex dropped out and why they dropped out. Why did RPRX feel compelled to hide these data from public view?

I’m all ears.